Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Correction to: Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis

Journal of the American Heart Association(2022)10.1161/jaha.121.020798Source: DataRank Database

Correction to: Loss of Endothelial Hypoxia Inducible Factor‐Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis is a research paper published in Journal of the American Heart Association (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Live enrichment

PubMed:35862234 PMC:PMC9496291 OpenAlex:https://openalex.org/W4284693996

goldLicense: cc-by-nc

journalhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.121.020798

publisherhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.121.020798

publisherhttps://www.ahajournals.org/doi/full/10.1161/JAHA.121.020798

journalhttps://doi.org/10.1161/jaha.121.020798

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35862234

Fields of Study

Cancer, Hypoxia, and MetabolismEicosanoids and Hypertension PharmacologyRenal and Vascular Pathologies

Keywords

MedicineHypoxia (environmental)Hypoxia-inducible factorsPulmonary hypertensionMuscle hypertrophyCardiologyInternal medicineFibrosisHeart failureCardiac hypertrophyVascular endothelial growth factorEndocrinologyVEGF receptorsBiologyChemistry

Sustainable Development Goals

SDG 0: Partnerships for the goals